HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NEK10
NIMA related kinase 10
Chromosome 3 Β· 3p24.1
NCBI Gene: 152110Ensembl: ENSG00000163491.18HGNC: HGNC:18592UniProt: A0A650C2C8
24PubMed Papers
21Diseases
0Drugs
8Pathogenic Variants
FUNCTIONAL ROLE
Kinase
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein kinase activitypositive regulation of MAP kinase activityregulation of ERK1 and ERK2 cascademucociliary clearanceciliary dyskinesia, primary, 44breast carcinomabreast cancerprimary ciliary dyskinesia
✦AI Summary

NEK10 is a divergent serine/threonine kinase within the NIMA-related kinase family with multifaceted roles in cell cycle regulation, DNA damage response, and ciliary function 1. Structurally, NEK10 contains a catalytic domain flanked by coiled-coil domains, armadillo repeats, and ubiquitin-associated domains 1. NEK10 uniquely functions as a tyrosine kinase, phosphorylating p53 at Y327 to regulate its transcriptional activity during genotoxic stress; NEK10 loss enhances cellular proliferation and increases DNA damage sensitivity 2. Additionally, NEK10 phosphorylates Ξ²-catenin at Tyr30 within the Axin complex to promote its degradation, and this function is critical for suppressing lung adenocarcinoma tumorigenesis 3. NEK10 also competes with O-GlcNAcylation for RYR1 phosphorylation, indirectly regulating skeletal muscle proteolysis in cancer-associated cachexia 4. In ciliated tissues, NEK10 regulates mucociliary clearance. Mutations in NEK10 cause primary ciliary dyskinesia-44, evidenced by ciliary ultrastructural defects 5. Clinically, NEK10 expression levels predict favorable outcomes in breast cancer, and genetic variants near NEK10 are associated with cancer-related fatigue severity 6.

Sources cited
1
NEK10 phosphorylates Ξ²-catenin at Tyr30 and regulates its turnover via the Axin complex; NEK10 deletion suppresses lung adenocarcinoma tumorigenesis
PMID: 38683979
2
NEK10-mediated phosphorylation of RYR1 competes with O-GlcNAcylation and regulates skeletal muscle proteolysis in cancer-associated cachexia
PMID: 35469018
3
NEK10 tyrosine phosphorylates p53 at Y327 to regulate its transcriptional activity; NEK10 loss increases proliferation and sensitivity to DNA damage
PMID: 32561851
4
NEK10 has catalytic domain flanked by coiled-coil domains, armadillo repeats, ATP binding site, and ubiquitin-associated domains; interacts with MAP3K1 and HSPB1
PMID: 41044802
5
NEK10 genetic variants are associated with cancer-related fatigue in colorectal cancer patients; NEK10 expression in liver tissue linked to fatigue risk
PMID: 40889272
6
Mutations in NEK10 cause primary ciliary dyskinesia-44 with corresponding ciliary ultrastructural defects
PMID: 37998386
Disease Associationsβ“˜21
ciliary dyskinesia, primary, 44Open Targets
0.71Strong
breast carcinomaOpen Targets
0.51Moderate
breast cancerOpen Targets
0.48Moderate
primary ciliary dyskinesiaOpen Targets
0.46Moderate
hypertensionOpen Targets
0.45Moderate
breast neoplasmOpen Targets
0.41Moderate
luminal A breast carcinomaOpen Targets
0.37Weak
estrogen-receptor positive breast cancerOpen Targets
0.37Weak
nerve plexus diseaseOpen Targets
0.33Weak
Uterine leiomyomaOpen Targets
0.31Weak
uterine fibroidOpen Targets
0.30Weak
cancerOpen Targets
0.30Weak
muscular diseaseOpen Targets
0.30Weak
HER2 negative breast carcinomaOpen Targets
0.30Weak
luminal B breast carcinomaOpen Targets
0.30Weak
lung adenocarcinomaOpen Targets
0.28Weak
colorectal cancerOpen Targets
0.28Weak
ovarian carcinomaOpen Targets
0.28Weak
ovarian endometrioid carcinomaOpen Targets
0.28Weak
estrogen-receptor negative breast cancerOpen Targets
0.28Weak
Ciliary dyskinesia, primary, 44UniProt
Pathogenic Variants8
NM_001394966.1(NEK10):c.1230+5G>CLikely pathogenic
Ciliary dyskinesia, primary, 44|not provided
β˜…β˜…β˜†β˜†2024
NM_001394966.1(NEK10):c.1985T>A (p.Met662Lys)Pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2025β†’ Residue 662
NM_001394966.1(NEK10):c.2182C>T (p.Pro728Ser)Likely pathogenic
Ciliary dyskinesia, primary, 44
β˜…β˜†β˜†β˜†2024β†’ Residue 728
NM_001394966.1(NEK10):c.489+1G>ALikely pathogenic
Ciliary dyskinesia, primary, 44
β˜…β˜†β˜†β˜†2024
NM_001394966.1(NEK10):c.1154dup (p.Ser386fs)Pathogenic
Ciliary dyskinesia, primary, 44
β˜…β˜†β˜†β˜†2022β†’ Residue 386
NM_001394966.1(NEK10):c.1869dup (p.His624fs)Pathogenic
Ciliary dyskinesia, primary, 44
β˜†β˜†β˜†β˜†2020β†’ Residue 624
NM_001394966.1(NEK10):c.2243C>T (p.Pro748Leu)Pathogenic
Ciliary dyskinesia, primary, 44
β˜†β˜†β˜†β˜†2020β†’ Residue 748
NM_001394966.1(NEK10):c.2317C>T (p.Arg773Cys)Pathogenic
Ciliary dyskinesia, primary, 44
β˜†β˜†β˜†β˜†2020β†’ Residue 773
View on ClinVar β†—
Related Genes
COX11Protein interaction77%LSP1Protein interaction77%SLC4A7Protein interaction77%TOX3Protein interaction77%GLYCTKShared pathway25%CCNQShared pathway25%
Tissue Expression6 tissues
Heart
100%
Brain
29%
Liver
13%
Lung
13%
Ovary
10%
Bone Marrow
2%
Gene Interaction Network
Click a node to explore
NEK10COX11LSP1SLC4A7TOX3GLYCTKCCNQ
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q6ZWH5
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.00LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.79 [0.63–1.00]
RankingsWhere NEK10 stands among ~20K protein-coding genes
  • #13,255of 20,598
    Most Researched24
  • #3,130of 5,498
    Most Pathogenic Variants8
  • #9,619of 17,882
    Most Constrained (LOEUF)1.00
Genes detectedNEK10
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Ξ²-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells.
PMID: 38683979
Proc Natl Acad Sci U S A Β· 2024
1.00
2
Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis.
PMID: 35469018
Nat Cell Biol Β· 2022
0.90
3
The NEK family of serine/threonine kinases as a biomarker for cancer.
PMID: 35037094
Clin Exp Med Β· 2023
0.80
4
Identifying mRNAs bound by human RBMY protein in the testis.
PMID: 21422736
J Reprod Dev Β· 2011
0.70
5
In Silico Analysis of Human NEK10 Reveals Novel Domain Architecture and Protein-Protein Interactions.
PMID: 41044802
Proteins Β· 2026
0.60